JP2017105790A5 - - Google Patents

Download PDF

Info

Publication number
JP2017105790A5
JP2017105790A5 JP2017004063A JP2017004063A JP2017105790A5 JP 2017105790 A5 JP2017105790 A5 JP 2017105790A5 JP 2017004063 A JP2017004063 A JP 2017004063A JP 2017004063 A JP2017004063 A JP 2017004063A JP 2017105790 A5 JP2017105790 A5 JP 2017105790A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
prg4
composition according
effective amount
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017004063A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017105790A (ja
JP6483164B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017105790A publication Critical patent/JP2017105790A/ja
Publication of JP2017105790A5 publication Critical patent/JP2017105790A5/ja
Application granted granted Critical
Publication of JP6483164B2 publication Critical patent/JP6483164B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017004063A 2009-05-22 2017-01-13 Prg4及びその治療調節作用の応用及び使用 Expired - Fee Related JP6483164B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18052509P 2009-05-22 2009-05-22
US61/180,525 2009-05-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014241399A Division JP6159704B2 (ja) 2009-05-22 2014-11-28 Prg4及びその治療調節作用の応用及び使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018200467A Division JP2019048824A (ja) 2009-05-22 2018-10-25 Prg4及びその治療調節作用の応用及び使用

Publications (3)

Publication Number Publication Date
JP2017105790A JP2017105790A (ja) 2017-06-15
JP2017105790A5 true JP2017105790A5 (cg-RX-API-DMAC10.html) 2017-10-26
JP6483164B2 JP6483164B2 (ja) 2019-03-13

Family

ID=43126811

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2012512085A Pending JP2012527485A (ja) 2009-05-22 2010-05-24 Prg4及びその治療調節作用の応用及び使用
JP2014241399A Expired - Fee Related JP6159704B2 (ja) 2009-05-22 2014-11-28 Prg4及びその治療調節作用の応用及び使用
JP2017004063A Expired - Fee Related JP6483164B2 (ja) 2009-05-22 2017-01-13 Prg4及びその治療調節作用の応用及び使用
JP2018200467A Pending JP2019048824A (ja) 2009-05-22 2018-10-25 Prg4及びその治療調節作用の応用及び使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2012512085A Pending JP2012527485A (ja) 2009-05-22 2010-05-24 Prg4及びその治療調節作用の応用及び使用
JP2014241399A Expired - Fee Related JP6159704B2 (ja) 2009-05-22 2014-11-28 Prg4及びその治療調節作用の応用及び使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018200467A Pending JP2019048824A (ja) 2009-05-22 2018-10-25 Prg4及びその治療調節作用の応用及び使用

Country Status (7)

Country Link
US (2) US9730865B2 (cg-RX-API-DMAC10.html)
EP (1) EP2432492B1 (cg-RX-API-DMAC10.html)
JP (4) JP2012527485A (cg-RX-API-DMAC10.html)
CN (1) CN102711796A (cg-RX-API-DMAC10.html)
CA (2) CA3110817C (cg-RX-API-DMAC10.html)
ES (1) ES2532526T3 (cg-RX-API-DMAC10.html)
WO (1) WO2010135736A2 (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010135736A2 (en) 2009-05-22 2010-11-25 Singularis Inc. Application and uses of prg4 and therapeutic modulation thereof
WO2011091000A2 (en) * 2010-01-19 2011-07-28 Singularis, Inc. Oral care compositions and methods
WO2014115022A1 (en) * 2013-01-25 2014-07-31 Baylor College Of Medicine A helper-dependent adenoviral gene therapy delivery and expression system
US9982027B2 (en) 2013-10-22 2018-05-29 Lubris Llc Control of rheological properties of mixed hyaluronate/lubricin solutions
US20150141328A1 (en) * 2013-11-18 2015-05-21 The Schepens Eye Research Institute Stimulation of human meibomian gland function
US10500250B2 (en) 2013-11-26 2019-12-10 Lubris Llc Compositions and methods for inhibiting intercellular interactions
EP2896429B1 (en) 2014-01-20 2018-07-18 COR S.a.r.l. Skin Protector
AU2016211694B2 (en) * 2015-01-26 2021-11-11 Lubris Llc Use of PRG4 as an anti-inflammatory agent
LT3300482T (lt) * 2015-05-19 2021-10-25 Lubris Llc Prg4 panaudojimas dinaminio regos aštrumo pagerinimui ir aukštesnės eilės aberacijų sumažinimui
US10695292B2 (en) 2015-06-23 2020-06-30 Fertin Pharma A/S Chewing gum composition for use in alleviation of xerostomia induced by radiotherapy treatment
CN105055949A (zh) * 2015-08-10 2015-11-18 孙霞 一种治疗小儿口腔溃疡的中药
CN108157358A (zh) * 2018-03-02 2018-06-15 沈阳汇翼宁消毒科技有限公司 一种消毒液及其制备方法
WO2019246522A1 (en) * 2018-06-21 2019-12-26 Lubris Llc Lubricin for use in wound healing
US20220008518A1 (en) * 2018-11-08 2022-01-13 The Schepens Eye Research Institute, Inc. Therapeutic approaches for tissue reconstruction and wound healing treatment
US12390488B2 (en) 2018-12-29 2025-08-19 Solventum Intellectual Properties Company Oral articles and methods of use
US12558305B2 (en) 2018-12-29 2026-02-24 Solventum Intellectual Properties Company Oral articles and methods of use
EP3982912A1 (en) 2019-06-14 2022-04-20 The Procter & Gamble Company Leave-on oral care compositions
EP3982913A1 (en) * 2019-06-14 2022-04-20 The Procter & Gamble Company Leave-on oral care compositions
WO2020248232A1 (en) * 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions
CN113950319A (zh) 2019-06-14 2022-01-18 宝洁公司 免洗型口腔护理组合物
WO2020248239A1 (en) * 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions
JP7272214B2 (ja) * 2019-09-24 2023-05-12 日油株式会社 デンタルプラーク・ステイン付着防止剤および口腔用組成物
CN111944595B (zh) * 2020-08-21 2022-08-09 健尔康医疗科技股份有限公司 一种医用外科器械用润滑剂及其制备和使用方法
CN121942025A (zh) * 2023-10-10 2026-04-28 华迎生物医学有限公司 循环液以及润滑性调整剂

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438100A (en) * 1980-04-25 1984-03-20 A/S Orthana Kemisk Fabrik Sterilized preserved, stable mucine-containing solutions
US4938963A (en) * 1988-11-22 1990-07-03 Parnell Pharmaceuticals, Inc. Method and composition for treating xerostomia
US5326558A (en) 1989-08-08 1994-07-05 Genetics Institute, Inc. Megakaryocytopoietic factor
US6433142B1 (en) 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
US7001881B1 (en) 1999-04-23 2006-02-21 Rhode Island Hospital Tribonectins
US6743774B1 (en) 1999-04-23 2004-06-01 Rhode Island Hospital Tribonectins
US6960562B2 (en) 1999-04-23 2005-11-01 Rhode Island Hospital, A Lifespan Partner Tribonectin polypeptides and uses thereof
GB2361870A (en) * 2000-05-03 2001-11-07 Zia Hashmi Treating xerostomia
EP1347993A2 (en) * 2000-12-29 2003-10-01 Glaxo Group Limited Superficial zone protein and methods of making and using same
US7071228B2 (en) * 2002-10-23 2006-07-04 Parks L Dean Method of treating musculoskeletal and connective tissue inflammations
US7415381B2 (en) 2003-01-09 2008-08-19 Rhode Island Hospital, A Lifespan Partner Joint friction sensing
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
US20060240037A1 (en) 2003-06-04 2006-10-26 Edward Fey Methods and compositions for the treatment and prevention of degenerative joint disorders
WO2005016130A2 (en) * 2003-08-14 2005-02-24 Wyeth Recombinant lubricin molecules and uses thereof
CA2558497A1 (en) * 2004-03-05 2005-09-15 Synthes (U.S.A.) Use of a mixture for the production of an agent for treating defective or degenerated cartilage in the production of natural cartilage replacement in vitro
US8034796B2 (en) * 2004-04-07 2011-10-11 The University Of Georgia Research Foundation, Inc. Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
WO2005102363A2 (en) 2004-04-20 2005-11-03 Mucosal Therapeutics Llc Methods of promoting cartilage healing or cartilage integration
US20080287369A1 (en) 2004-07-23 2008-11-20 Jay Gregory D Compositions and Methods for Viscosupplementation
ES2344911T3 (es) * 2004-08-02 2010-09-09 Glaxo Group Limited Composicion novedosa para tratar la xerostomia.
EP1827478A4 (en) * 2004-12-03 2009-08-05 Mucosal Therapeutics Llc METHODS OF TREATING JOINED OR SICK JOINTS
US20070111327A1 (en) 2005-05-05 2007-05-17 Jay Gregory D Methods of detecting lubricin
US8057458B2 (en) 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US20090068247A1 (en) 2007-09-12 2009-03-12 Mucosal Therapeutics Biocompatible devices coated with a tribonectin and methods for their production
US20090104148A1 (en) 2007-09-18 2009-04-23 Jay Gregory D Treatment and prevention of joint disease
HRP20150097T1 (hr) 2008-05-07 2015-03-27 The Regents Of The University Of California Terapijska nadopuna i poboljšanje vlaženja površine oka
US8506944B2 (en) 2008-05-07 2013-08-13 The Regents Of The University Of California Replenishment and enrichment of ocular surface lubrication
EP2368076A1 (en) * 2008-12-19 2011-09-28 Kautex Textron CVS Limited Vehicular fluid heater
ES2534082T3 (es) 2009-01-13 2015-04-17 Lubris Llc Modulación terapéutica de la lubricación del límite del epitelio vaginal
WO2010135736A2 (en) 2009-05-22 2010-11-25 Singularis Inc. Application and uses of prg4 and therapeutic modulation thereof
CA2771110C (en) 2009-08-13 2019-02-26 Singularis, Inc. Prg4 treatment for interstitial cystitis
WO2011091000A2 (en) 2010-01-19 2011-07-28 Singularis, Inc. Oral care compositions and methods
US20130116186A1 (en) 2011-10-04 2013-05-09 Rhode Island Hospital, A Lifespan Partner Lubricin injections to maintain cartilage health
US9982027B2 (en) 2013-10-22 2018-05-29 Lubris Llc Control of rheological properties of mixed hyaluronate/lubricin solutions

Similar Documents

Publication Publication Date Title
RU2471867C2 (ru) Гиалуронидаза и способ ее применения
JP6483164B2 (ja) Prg4及びその治療調節作用の応用及び使用
MX2011008616A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
PH12012500756A1 (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
JP2017505338A5 (cg-RX-API-DMAC10.html)
NZ600544A (en) Compositions and methods for the treatment of angiogenesis-related eye diseases
RU2013139651A (ru) Новые соединения, влияющие на пищевое поведение
ES2866957T3 (es) Agente terapéutico del síndrome de Hunter y método de tratamiento
RU2010114041A (ru) Применение пептида в качестве терапевтического средства
RU2012136530A (ru) Новые соединения, влияющие на пищевое поведение
ES2585253T3 (es) Composiciones para prevenir la pérdida de cabello o para estimular el crecimiento del cabello
RU2015123315A (ru) Пептиды, стимулирующие подкожный адипогенез
JP2016501866A5 (cg-RX-API-DMAC10.html)
EP4144362A1 (en) Compositions comprising short-acting hormones for treating or preventing obesity and pumps comprising said composition
Muzio et al. Prosthetic rehabilitation of a child affected from anhydrotic ectodermal dysplasia: a case report
CN108135965B (zh) 用于伤口愈合的含p物质的药物组合物
JP2013543378A5 (cg-RX-API-DMAC10.html)
JP2022502359A5 (cg-RX-API-DMAC10.html)
JP2009500045A5 (cg-RX-API-DMAC10.html)
RU2008134118A (ru) Внутрижелудочковая доставка белка при боковом амиотрофическом склерозе
EP4706651A3 (en) New formulations and uses
AU2010230862A1 (en) Compositions and methods for treatment of aortic fibrosis
JP2010524910A5 (cg-RX-API-DMAC10.html)
US9744110B2 (en) Method of treating conditions of the eyelid
ES2255988T3 (es) Utilizacion de una emulsion de aceite en agua para la preparacion de un medicamento.